# The Safety and Efficacy of the Suture-Mediated Closure System

Study · id `cardio:ct-nct05841836` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05841836](<https://clinicaltrials.gov/study/NCT05841836>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05841836

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 228 participants.

## Technical summary

Registry record NCT05841836. Randomized; no masking; primary purpose treatment. Start 2022-10-26 (actual); primary completion 2023-05-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 228 participants (planned count; ClinicalTrials.gov record NCT05841836, source copy `cardio:ctgov-nct05841836-2023-05-03`, retrieved 2026-10-31)
- Started: 2022-10-26 (actual) (ClinicalTrials.gov record NCT05841836, source copy `cardio:ctgov-nct05841836-2023-05-03`, retrieved 2026-10-31)
- Primary completion: 2023-05-30 (anticipated) (ClinicalTrials.gov record NCT05841836, source copy `cardio:ctgov-nct05841836-2023-05-03`, retrieved 2026-10-31)
- Completion: 2023-07-30 (anticipated) (ClinicalTrials.gov record NCT05841836, source copy `cardio:ctgov-nct05841836-2023-05-03`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT05841836, source copy `cardio:ctgov-nct05841836-2023-05-03`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05841836-2023-05-03`, retrieved 2026-10-31)

## The registry's words

- Brief title: The Safety and Efficacy of the Suture-Mediated Closure System
- Condition: Peripheral Arterial Disease
- Condition: Arterial Puncture
- Intervention (Device): the Suture-Mediated Closure System
- Intervention (Device): Perclose ProGlide Suture-Mediated Closure System
- Lead sponsor: Zhejiang Zylox Medical Device Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Zhejiang Zylox Medical Device Co., Ltd. (`cardio:org-zhejiang-zylox-medical-device-co-ltd`)

## Provenance

Content hash: 186ede3afab4262d33e2a0db74c9e0dc7f06275bb28394390be0012cd30fa307
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
